Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.

Grétarsdóttir HM, Cunningham JL, Rasmusson A, Burman J, Kultima K, Paucar M, Svenningsson P, Constantinescu R, Niemelä V

Open source

DOI
10.1007/s00415-026-14112-5
Published
2026 Sep 12
Container
Journal of neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00415-026-14112-5,
  title = {Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.},
  author = {Grétarsdóttir HM and Cunningham JL and Rasmusson A and Burman J and Kultima K and Paucar M and Svenningsson P and Constantinescu R and Niemelä V},
  year = {2026},
  journal = {Journal of neurology},
  doi = {10.1007/s00415-026-14112-5},
  url = {https://doi.org/10.1007/s00415-026-14112-5}
}

RIS

TY  - JOUR
TI  - Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.
AU  - Grétarsdóttir HM
AU  - Cunningham JL
AU  - Rasmusson A
AU  - Burman J
AU  - Kultima K
AU  - Paucar M
AU  - Svenningsson P
AU  - Constantinescu R
AU  - Niemelä V
PY  - 2026
JO  - Journal of neurology
DO  - 10.1007/s00415-026-14112-5
UR  - https://doi.org/10.1007/s00415-026-14112-5
ER  - 

APA

HM, G., JL, C., A, R., J, B., K, K., M, P., P, S., R, C., & V, N. (2026). Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.. Journal of neurology. https://doi.org/10.1007/s00415-026-14112-5

Source records